LY335979
A substance being studied in the treatment of cancer. LY335979 may help kill cancer cells that are resistant to anticancer drugs. Also called zosuquidar trihydrochloride.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.